Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SOLENSIA DIN 02518449

Status: Marketed
Holder: ZOETIS CANADA INC
Molecule: FRUNEVETMAB

Health Canada record

Active ingredient(s)FRUNEVETMAB 7 MG
Dosage formSolution
RouteSubcutaneous
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date14-Apr-2022
Current status date14-Apr-2022
SourceHealth Canada DPD

Establishment licence of the holder

Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).

No Canadian shortage report is currently matched to this DIN.

Notices of Compliance

NOCDateSubmissionReason
263262021-07-27New Drug Submission (NDS)
Request a quote for SOLENSIA

How to read a Canadian DIN record